Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Onureg

Azacitidine

Open in the dashboard

Part D claims

1,863

Prescriptions dispensed, refills included

Drug cost

$43,646,130

Paid at the pharmacy, in all

Prescribers

117

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,863 claims for Onureg (azacitidine) from 117 prescribers, at a total drug cost of $43.6 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 32 states and territories
Part D claims for Onureg by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
FL 16 226 $5,579,821
TX 10 179 $4,154,766
NJ 9 163 $3,807,544
OH 8 147 $3,427,806
NC 7 129 $3,033,574
IN 7 123 $2,848,566
WA 5 97 $2,415,692
CA 5 97 $2,242,225
PA 7 97 $2,192,255
GA 5 68 $1,393,652
IL 4 65 $1,590,450
LA 4 62 $1,362,147
NY 4 57 $1,358,272
KY 4 56 $1,225,680
UT 3 44 $834,378
The other 17 states and territories
State Prescribers Claims Drug cost
TN 2 30 $711,811
NE 2 27 $616,561
MO 1 15 $289,770
MI 1 14 $354,694
AL 1 14 $334,772
MD 1 13 $326,949
CO 1 13 $332,698
OK 1 13 $283,232
WV 1 13 $337,650
MN 1 13 $335,644
SC 1 13 $337,650
NV 1 13 $384,480
KS 1 13 $311,172
AR 1 13 $320,631
WI 1 13 $323,555
SD 1 12 $314,736
MT 1 11 $263,299

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 8 of 8
Part D claims for Onureg by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 64 969 $22,545,059
Hematology 13 243 $5,575,152
Medical Oncology 14 219 $5,350,467
Nurse Practitioner 13 200 $4,769,571
Physician Assistant 5 79 $1,996,825
Internal Medicine 5 64 $1,481,013
Hospitalist 2 60 $1,398,853
Hematopoietic Cell Transplantation and Cellular Therapy 1 29 $529,190

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Gabriela Sanchez Petitto Hematology TX 50 $877,790 None on record
Kelly Mitchell Nurse Practitioner NJ 37 $815,869 None on record
Joshua Zeidner Hematology-Oncology NC 36 $884,061 None on record
Seyed Hamid Sayar Hematology-Oncology IN 35 $780,356 None on record
Leland Metheny Hospitalist OH 34 $813,321 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for azacitidine

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record